Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Provid and Acesys Form US-China Medicinal Chemistry CRO Alliance

publication date: Sep 8, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Provid Pharmaceuticals of New Jersey and Acesys Pharmatech of China have formed a US-China CRO alliance. The new group puts together Provid’s US-based drug discovery expertise and project management capabilities with Acesys’s China-based medicinal chemistry resources and favorable cost structure. According to the announcement, the alliance will offer all aspects of medicinal chemistry for pharmaceutical and biotech clients. More details...

Stock Symbols: (HKEX: 2285) (NSDQ: CBTE) (NYSE: SGP) (NYSE: MRK)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners